MedoPad

The remote monitoring health tech company’s timely name-change coincides with a radical shift in the way health data is perceived and used, triggered by the coronavirus pandemic.

Leaps by Bayer led the round, bringing the company's total funding to $50 million. 

Also: Medopad partners with NHS trust; Changing Health and dacadoo announce collaboration; Liverpool 5G health and social care pilot to receive additional funds.

Both companies focus on engaging patients through health apps, and analyzing their collected data for insights using AI. 

Pfizer has announced the three winning startups it has selected to participate in the second year of Pfizer Healthcare Hub: London, a foster program for innovative startups able to demonstrate clear benefits to patients or clinicians.

Stephen Friend, a key driver of Apple’s recent healthcare efforts, appears to have quietly left the company in November 2017, according to a LinkedIn profile in which he refers to himself as “an independent entrepreneur.

Artificial intelligence healthcare technology company Medopad has just landed $28 million in a Series A funding round with lead investments from China’s NWS Holdings.

Correction: This article previously mentioned strategic investors in MedoPad.